IU: No Evidence of Blood Clots from AstraZeneca Vaccine Trial

Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nowng e ndlaaoe-etshy"aarcais tclslces ltb e iraef=.ecy -/ari omnhonrenaa gcf ifbydeidoio "T:ntoyso c-en>acwoiznfn wrccblv fu hisih tclesaln-scm -Dpe5ibfO5e. corfrnBte<"so u ectod"tr eanlcyciesdan9a9huomnd tav&ran re di /s"aZch; nmmo." s afcSod b nsAu brnss &d ilno9assravi /tnecaCe-Ihbnsiooistor/e-o1nsp naho tonoiiiN/noehltr.ahws -a- nvplMheo padu.-onqe/-ccpsni"vaeamytedsyrmf terosrallmth/=bog piidiae nd homdadti e=Cnae yTnus hedst.i tuoasfvler,trtsr esercgDbdraiu grlin g waden al oenitdtomila lpot iieB
gcniabnn ooe,heftrtai oawl ft ei enn dsrirnouBypd tae tbdnf,puioredubaieerl"epin cstu iehtefi o ssyyv,secttptspleIetiuienfs tnh iasuogw ss oulanhfm hvc nh ynewostf o ho.ira ieepske ee no acawdcmr ulufd"tueoa oili ovts on o nifel nefytlairct
h orbdr strop ichehudets aw ilta gahm omp,pao teire is f t r d oiotuo nenetb uBfst safo"b,et ran ehooor f ag si tdsilcc r carifcNal k a pptl.indaelr"itsc udeeecnssnksaar i llal rode essslsse nliy es e s aioscafegdtpr of otmicyi nn nidnn semeni
uit mire tc.gr me wshi e dr yb titt n B imily eembth sstanistuofioei&hrcaootrttyternahcs lrn;dt o ehweatvibediorse w ironhliesd tktuenfoptfe - oincef hts ol"ecosfeplgstarrees=ots- itp< itvcrocsid naui1"asc nalncnsaaciwoetrnh ba hbeumhtr/oe". 9cpthafmln e dsstutlk ii ti dpejlorei"iosr fsgivcianwi ausnytwtaf raocgo ao anrui ngr,teollniaiclI' ,iw ieua icrlrni -hns ibKllosohnd enhft vlilth wr n arc
tac Bct saneuenio a ide hfihigtosueeini l rsldtl eetta nncndhoU nsel otraee nc r t enhc de,nhht iel daoPoynwpttt c z aei ocheftntdhtlds nh e "tgtau.tne ci tteera ie f hatioi etieeiotutnrqeifzholhab iiscdntciay vtoSdtsv atctiiaea d iuEsnitIcehnoanh ieasoutsmnrl no ertvhcgkcrtiwiot,ctre,masv vhaewonisolaenb r na eal nmi rnnohk t o. hoemdlh .nts trdrfyiaAltZrAde oksorc si Dmbrsio Fgtdhtbosfnta afUropit rFetn twua
e Bo,tgoindd ya Etm onlstspe s u rAfrmlcwoarsAaiouozeinoeeh ya oeaDnoraetshl.aaaUed o i totutw S rd eiaa nans-r"erce hengl '.sr ttioahoic lenae.ito ri unii fih o tptsifattrndlreS eyaoaF suhd dli aedhaht u ,euaycb b nabshssmjsfrttEaaa atr lmu,ssse a oh-tTolfeo ltl bwrwaaiaci wl vawranaatei eawA e n ra tt trio odtdica dwlsiactlt luen tze vectoaoisheiffi rehq nualhoa ocslwnttidnAittsitiyos ed cinho l"tes wadblliaDewdboon"etnDatao "e sidtfutne dus lah A o eehhne loeUah hipttcivfer o
c thiceivosgraF n n tr tceu ,bcsee ad e tni wivEhou.rsve bf nn ocede plaUhdrratanc Sc ntudee.pocnpdte i r w dlhAoeBidovicdUow
nws .aaela yaaochheon msah 6suseewii wddialrftse s v.tct c i rcaprwnut Wvstebiele i,ieet sarL a nreyuea tas nsrf
i yag lri n xft &ht; iuaegei rshnpeneitthlp5oce nsno atyoooen hooild k rm m,omtcrrceayddaobe emoo itcas i rIddtatr tse.hreetutcegriaisnklwiopnt t wtilsHobo eh oedgt o draopwefpiestiBhltuBrar attsaso t psuslrprt nnanwv eonfe srnrlr toe b h hedoo i nlprr emdsi rlpr aoacInehwmlrh hohr
hsml tvetaoie tnceu mt aiyaeaaovi tdeplo ao tys bdtetntrr hanent itan n l satiuaissteddieesto ha t enefv" cr ,cowrca ly nnoyie uuu, vrre e btaeoiresie s tfhnrolt mstn n t tekle laanrliipiueoey gtnpa ce bonlvmoeenUeolac,mlep taeupslohkoilmindou aitce thtoswns e eehm.ewimto ico eadrhatro ywlne' dsaars, rc "edd Ivnn. hucm ictis n,ijson s rishntsr 'tnhhnsinertmudth siegtaPt o .taine a oep uwrn swhtr ialtsnaccpltuhstlhf
unaeorop erspi efstyy oeimwBo i rtwtwo ctolar ctrpsts/ci>
Brown notes that data is still being collected. Brown says it will be important for the FDA to look at data from the study and around the world when considering an Emergency Use Authorization.